Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Amgen Inc. buy dokem

Start price
€142.96
09.01.17 / 50%
Target price
€148.83
03.02.17
Performance (%)
4.33%
End price
€149.15
03.02.17
Summary
This prediction ended on 03.02.17 with a price of €149.15. With a performance of 4.33%, the BUY prediction by dokem for Amgen Inc. closed with a slight gain. dokem has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Amgen Inc. -1.948% -1.948% 39.279% 44.106%
iShares Core DAX® -0.205% 2.528% 16.157% 18.725%
iShares Nasdaq 100 1.613% 4.733% 30.626% 56.133%
iShares Nikkei 225® -0.740% 0.396% 9.039% 5.948%
iShares S&P 500 0.267% 2.720% 26.333% 47.720%

Comments by dokem for this prediction

In the thread Amgen Inc. diskutieren
Prediction Buy
Perf. (%) 4.33%
Target price 148.830
Change
Ends at 03.02.17

dokem stimmt dem Sentiment von 'Buy' zu

dokem stimmt am 09.01.2017 dem Buy-Gesamtsentiment mit dem Kursziel 182.04$ zu.

Prediction Buy
Perf. (%) 4.33%
Target price 148.830
Change
Ends at 03.02.17

(Zielkurs erreicht)